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Our previous research involving 167 nuclear families from the Autism Genetic Resource Exchange (AGRE) dem-
onstrated that two intronic SNPs, rs1861972 and rs1861973, in the homeodomain transcription factor gene
ENGRAILED 2 (EN2) are signiﬁcantly associated with autism spectrum disorder (ASD). In this study, signiﬁcant
replication of association for rs1861972 and rs1861973 is reported for two additional data sets: an independent
set of 222 AGRE families (rs1861972–rs1861973 haplotype, ) and a separate sample of 129 NationalPp .0016
Institutes of Mental Health families (rs1861972–rs1861973 haplotype, ). Association analysis of thePp .0431
haplotype in the combined sample of both AGRE data sets (389 families) produced a P value of .0000033, whereas
combining all three data sets (518 families) produced a P value of .00000035. Population-attributable risk cal-
culations for the associated haplotype, performed using the entire sample of 518 families, determined that the risk
allele contributes to as many as 40% of ASD cases in the general population. Linkage disequilibrium (LD) mapping
with the use of polymorphisms distributed throughout the gene has shown that only intronic SNPs are in strong
LD with rs1861972 and rs1861973. Resequencing and association analysis of all intronic SNPs have identiﬁed
alleles associated with ASD, which makes them candidates for future functional analysis. Finally, to begin deﬁning
the function of EN2 during development, mouse En2 was ectopically expressed in cortical precursors. Fewer En2-
transfected cells than controls displayed a differentiated phenotype. Together, these data provide further genetic
evidence that EN2 might act as an ASD susceptibility locus, and they suggest that a risk allele that perturbs the
spatial/temporal expression of EN2 could signiﬁcantly alter normal brain development.
Introduction
Individuals diagnosed with autism spectrum disorder
(ASD [MIM 209850]) exhibit deﬁciencies in commu-
nication and reciprocal social interactions that are often
accompanied by restricted or repetitive interests and be-
haviors. Autopsy and neuroimaging studies suggest that
ASD is caused in part by abnormal brain development
(Bauman and Kemper 1985, 1986, 1994; Ritvo et al.
1986; Gaffney et al. 1987; Courchesne et al. 1988, 2001,
2003; Murakami et al. 1989; Kleiman et al. 1992; Kem-
per and Bauman 1993; Hashimoto et al. 1995; Cour-
chesne 1997; Bailey et al. 1998). Twin, family, and dis-
ease-modeling studies support a polygenic multifactorial
Received June 17, 2005; accepted for publication August 26, 2005;
electronically published October 5, 2005.
Address for correspondence and reprints: Dr. James H. Millonig,
Center for Advanced Biotechnology and Medicine, 679 Hoes Lane,
Piscataway, NJ 08854-5638. E-mail: Millonig@CABM.rutgers.edu
* These authors contributed equally to this work.
 2005 by The American Society of Human Genetics. All rights reserved.
0002-9297/2005/7705-0014$15.00
basis in the etiology of ASD (Folstein and Rutter 1977;
Ritvo et al. 1985; Risch et al. 1999; Folstein and Rosen
2001; Liu et al. 2001; Alarcon et al. 2002; Auranen et
al. 2002).
The CNS structure most consistently affected in in-
dividuals with autism is the cerebellum. In 24 of 29
autopsy samples from different individuals, cerebellar
defects have been reported, with a decrease in the num-
ber of Purkinje cells being present in 23 of these 24
samples. Neurodegenerative signs are mostly absent
from these samples, which suggests that these pheno-
types are developmental (Bauman and Kemper 1985,
1986, 1994; Ritvo et al. 1986; Kemper and Bauman
1993; Courchesne 1997; Bailey et al. 1998; Palmen et
al. 2004). In addition, neuroimaging studies have con-
sistently demonstrated posterior cerebellar hypoplasia
(Gaffney et al. 1987; Courchesne et al. 1988, 2001,
2003;Murakami et al. 1989; Kleiman et al. 1992;Hash-
imoto et al. 1995; Courchesne 1997). Although the cer-
ebellum has been classically considered a motor control
center, functional imaging studies indicate that the cer-
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ebellum is also active during cognitive tasks that are
defective in ASD, including language and attention (Kim
et al. 1994; Raichle et al. 1994; Gao et al. 1996; Ak-
shoomoff et al. 1997; Allen et al. 1997; Courchesne
1997; Courchesne and Allen 1997; Allen and Cour-
chesne 2003; Corina et al. 2003; McDermott et al.
2003). Thus, the identiﬁed cerebellar defects may con-
tribute directly to some of the behavioral abnormalities
associated with ASD. In turn, genetic alterations that
perturb cerebellar development may contribute to ASD
susceptibility.
ENGRAILED 2 (EN2 [MIM 131310]) was selected
as a candidate gene because En2mouse mutants display
anatomical phenotypes in the cerebellum that are sim-
ilar to those reported for individuals with autism. Two
mouse mutants exist for En2: a knockout and a trans-
genic that causes the developmental misexpression of
the gene. In both mutants, adult mice are nonataxic but
the cerebellum is hypoplastic, with a decrease in the
number of Purkinje cells, indicating that En2 misreg-
ulation negatively impacts cerebellar development (Mil-
len et al. 1994, 1995; Kuemerle et al. 1997; Baader et
al. 1998, 1999).
EN2 was also selected as a candidate gene because
of previous linkage and association studies. EN2 maps
to 7q36, a chromosomal region that has provided sug-
gestive evidence for linkage to ASD in Autism Genetic
Resource Exchange (AGRE) families that largely over-
lapped with the pedigrees used for our initial family-
based association study (Liu et al. 2001; Alarcon et al.
2002). 7q36 has also yielded suggestive linkage for ASD
and dysphasia, another language disorder, in one other
study (Auranen et al. 2002). However, most reports ei-
ther have not demonstrated linkage with 7q36 or have
not tested markers spanning telomeric chromosome 7
(Risch et al. 1999; Folstein and Rosen 2001). In addi-
tion, signiﬁcant association between EN2 and autism
has been reported previously for a PvuII RFLP mapped
by Southern analysis to the 5′ region of the gene (Logan
and Joyner 1989; Petit et al. 1995). Thus, both the
cerebellar phenotypes of mouse En2 mutants and pre-
vious human genetic analysis indicated that EN2 was
a suitable candidate gene to test for association with
ASD.
Human EN2 spans 8.1 kb of genomic DNA and con-
sists of two exons separated by a single 3.3-kb intron.
We have previously tested four SNPs (rs3735653,
rs1861972, rs1861973, and rs2361689) that span the
majority of the EN2 gene for association with ASD in
167 AGRE families (AGRE I data set) (Gharani et al.
2004). The rs3735653 and rs2361689 SNPs are locat-
ed in exon 1 and exon 2, respectively, whereas the
rs1861972 and rs1861973 SNPs are both located in the
single intron. Signiﬁcant association was observed for
the common alleles of rs1861972 and rs1861973, both
individually and as a haplotype (Gharani et al. 2004).
In contrast, the two exonic SNPs were not associated
with ASD. Four-SNP haplotype analysis further re-
vealed that the common alleles of rs1861972 and
rs1861973 were not consistently associated with ASD,
suggesting that rs1861972 and rs1861973 were non-
functional polymorphisms in LD with the functional
variant(s) located elsewhere in the gene (Gharani et al.
2004).
The current study now extends these observations
in three ways. First, replication of the association of
rs1861972 and rs1861973 with ASD was tested in
two additional samples: 222 additional AGRE families
(AGRE II data set) and 129 independent families from
the National Institute of Mental Health (NIMH) col-
lection. Second, to deﬁne the genomic region associated
with ASD and to identify alleles for future functional
studies, LD mapping in the AGRE I data set was per-
formed by analyzing 14 additional polymorphisms,
which included the previously associated PvuII RFLP.
Third, to further investigate the role of EN2 in neuronal
development, mouse En2 was ectopically misexpressed
in primary rat cortical precursors. These experiments
have demonstrated both strong genetic association for
EN2 with ASD, further supporting the possibility that
EN2 acts as an ASD susceptibility locus, and have
provided functional evidence that a risk allele that
causes EN2 misexpression could disrupt normal brain
development.
Material and Methods
Subjects
Families recruited to AGRE and to the NIMH Center
for Collaborative Genetic Studies were used for this
study (Risch et al. 1999; Geschwind et al. 2001). All
research was approved by the UMDNJ–Robert Wood
Johnson Medical School Institutional Review Board.
The AGRE I data set includes 167 families used in
our original study (Gharani et al. 2004), and the AGRE
II data set includes 222 additional families. AGRE is a
central repository of family DNA samples created by the
Cure Autism Now Foundation and the Human Biolog-
ical Data Interchange (see AGRE Web site). Family se-
lection criteria have been described elsewhere (Gesch-
wind et al. 2001; Liu et al. 2001). Families recruited by
AGRE comprise at least two affected siblings (diagnosed
with autism, Asperger syndrome, or pervasive devel-
opment disorder–not otherwise speciﬁed [PDD-NOS]),
one or both parents, and additional affected and un-
affected siblings when available. Although unaffected
siblings have not undergone an Autism Diagnostic
Interview–Revised (ADI-R) evaluation, for the com-
bined AGRE sample, extensive neurological, psycholog-
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ical, and medical evaluations are available for 69 of the
277 unaffected siblings. None of the unaffected siblings
display characteristics of a broad autism phenotype.
Fragile X information was available for 381 of the 399
AGRE families considered for use in this study. Ten fam-
ilies were removed because at least one individual per
family displayed a pre-, intermediate, or full fragile X
mutation state. Karyotypic data were available for 109
AGRE families used in this study. Five karyotypically
abnormal families with a duplication of SNRPN on
chromosome 15q12 (amarker for cytogenic abnormality
at the chromosome 15 autism critical region) were also
removed.
The NIMH data set is managed and distributed by
the NIMHCenter for Collaborative Genetic Studies. The
center is operated under an NIMH contract to Rutgers
University and a subcontract to Washington University
(see NIMH Center for Collaborative Genetic Studies
Web site). The data set includes 143 families. Of these
families, 14 are also included in the AGRE data sets and
so were removed from our analysis (seeNIMHWeb site).
These families were originally recruited as part of an
NIMH-funded linkage study (grant RO1-MH S2708) at
Stanford University School of Medicine. Selection cri-
teria have been described elsewhere (Risch et al. 1999),
and anonymous data on family structure, age, and sex,
as well as diagnostic interview data and status, are avail-
able online (see NIMH Web site). Families in the NIMH
data set have at least two affected siblings or more-
distantly related individuals (e.g., cousins) with a diag-
nosis of autism or another pervasive developmental dis-
order, without any associated primary disorder such as
fragile X syndrome. The majority of the families in-
cluded in the collection are affected-sib multiplex fam-
ilies. Of the 53 unaffected children, 46 have undergone
ADI-R evaluation, and these individuals did not meet
criteria for ASD (Risch et al. 1999). The diagnosis for
six individuals was uncertain, and one individual did
not meet ASD criteria by the ADI-R but exhibited be-
havioral and developmental abnormalities. These seven
individuals were excluded from our analysis. No kary-
otype data were available for the NIMH data set. For
our analysis, individuals were considered affected under
a narrow diagnostic deﬁnition if they were diagnosed
with autism, whereas they were considered affected un-
der a broad diagnostic deﬁnition if they were diagnosed
with autism, Asperger syndrome, or PDD-NOS.
Thirty-two of the families in the new AGRE sample
and 20 in the NIMH sample include multiple births. In
the AGRE sample, there are 19 families with MZ mul-
tiple births (16 MZ twin pairs that are autism:autism
concordant, 2 MZ twin pairs that are autism:PDD dis-
cordant, and 1 set of MZ quadruplets that are autism:
autism concordant), 11 families with DZmultiple births
(9 twin pairs and 2 sets of triplets), and 2 additional
families with twins of unknown zygosity. In the NIMH
sample, 10 families have MZ twins (9 MZ twin pairs
that are autism:autism concordant and 1 that is autism:
PDD discordant), 9 families have DZ twins, and 1 family
has a triplet consisting of an MZ pair and a third DZ
sibling (all are autism:autism concordant). DNA is avail-
able for all twins in both data sets, and all siblings were
genotyped. All DZ siblings are included in the data anal-
ysis, but, for MZ siblings, only the ﬁrst MZ cotwin was
selected for analysis.
DNA Analysis
Samples in the AGRE II and NIMH data sets were
genotyped for the SNPs rs1861972 and rs1861973 by
use of simplex Pyrosequencing assays and the automated
PSQ HS 96A platform as described elsewhere (Ronaghi
et al. 1998; Ahmadian et al. 2000).
An additional 14 polymorphisms (ﬁg. 1) were geno-
typed in the AGRE I data set; 12 were identiﬁed by
dbSNP (see dbSNP Web site). The PvuII RFLP, previ-
ously reported to be associated with autism (Petit et al.
1995), was identiﬁed as a /CG insertion/deletion poly-
morphism by sequence analysis and by comparison with
published RFLP reports (Logan and Joyner 1989). An
additional intronic SNP (ss38341503) was identiﬁed by
sequence analysis. Each dbSNP polymorphism was se-
quence veriﬁed using 24 unrelated individuals (23whites
and 1 individual of Hispanic/Latino descent) prior to the
design of genotyping assays. Pyrosequencing, the ligase-
detection reaction and Luminex cytometry (Iannone et
al. 2000), RFLP, or tetra-primer ampliﬁcation refractory
mutation system (ARMS)–PCR assays (see Tetra-primer
ARMS-PCR Web site) were used to genotype 13 of the
polymorphisms (Ye et al. 2001), whereas a standard
PCR and gel electrophoresis assay was used to genotype
the rs6150410 insertion/deletion polymorphism (ﬁg. 1).
Primers were designed using publicly available software
(see Pyrosequencing Technical Support and Primer3Web
sites). The primer sequence and PCR conditions used for
each polymorphism are described in appendix B (online
only).
Statistical Analysis
Prior to data analysis, each polymorphism was as-
sessed for deviations from Hardy-Weinberg equilibrium
by use of genotype data from all parents and standard
formulae. The DNA from the MZ twins was used as a
genotyping internal control, with complete genotypic
concordance observed for all MZ cotwins. Genotypes
were checked for Mendelian inconsistencies by use of
the PEDCHECK program, version 1.1 (O’Connell and
Weeks 1998), and all identiﬁed Mendelian errors were
corrected by regenotyping individual samples. In the
AGRE I data set, for 9 individuals, genotyping data were
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Figure 1 Schematic representation of the human EN2 gene, with the location, name, and MAF of, as well as the genotyping method
used for, the polymorphisms tested for association with ASD.
missing for four markers. Since recombination events are
not expected at a high frequency, given the small (!8
kb) intermarker distances, haplotype inconsistencies
were identiﬁed by the SIMWALK program, version
2.86 (Weeks and Lathrop 1995). For each of the 14
polymorphisms genotyped in the AGRE I data set,
three-marker haplotype analysis with rs1861972 and
rs1861973 was performed. Regenotyping of ﬂagged
polymorphisms identiﬁed only 155 (1.5%) of the 10,360
genotypes that could not be resolved. These genotypes
were distributed between the 14 polymorphisms, with a
range from 45 genotypes for rs1345514 to 7 genotypes
for rs3824068. For rs1861972 and rs1861973, geno-
typed in the AGRE II and NIMH data sets, two SNP
haplotype analyses identiﬁed only 12 (0.7%) of the
1,741 genotypes that could not be resolved by regeno-
typing. The linkage disequilibrium (LD) coefﬁcient (D′)
for the 18 different polymorphisms was calculated in the
AGRE I data set by use of the parental genotypes and
the GOLD program, version 1.0 (Abecasis and Cookson
2000).
All single and multilocus association analyses were
performed using the program PDTPHASE (version 2.404),
which also calculates the corresponding P values. Both
haplotype-speciﬁc P values and global P values (with
adjustments for all possible common haplotypes with a
frequency 15%) are calculated by the PDTPHASE pro-
gram. PDTPHASE is a component of the UNPHASED
package of association-analysis programs (Dudbridge
2003). PDTPHASE is a modiﬁcation of the pedigree-
based transmission/disequilibrium test (PDT) (Martin et
al. 2000). PDTPHASE, like the PDT, was designed to
allow the use of data from related triads and disease-
discordant sibships from extended pedigrees when test-
ing for transmission disequilibrium. It determines the
presence of association by testing for unequal transmis-
sion of either allele from parents to affected offspring
and/or unequal sharing of either allele between discor-
dant sibships. Informative extended pedigrees contain at
least one informative triad (i.e., an affected child with
at least one parent heterozygous at the marker) or dis-
cordant sibship (i.e., at least one affected and one un-
affected sibling with different marker genotypes). PDT-
PHASE has a number of advantages over the PDT that
increase the statistical power of our analysis. It can han-
dle missing parental data, is able to perform multilocus
analysis, and includes an expectation-maximization al-
gorithm that calculates maximum-likelihood gametic
frequencies under the null hypothesis, allowing the in-
clusion of phase-uncertain haplotypes.
The total numbers of families, triads, and discordant
sib pairs (DSPs) used for the rs1861972 and rs1861973
replication analyses in the AGRE II and NIMH data sets
as well as the extension of the LD map in the original
AGRE I data set are listed in table 1.
In all the haplotype analyses, haplotypes with a fre-
quency !5% were pooled for analysis. PDTPHASE, like
the PDT, can calculate two global scores: the PDTsum
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Table 1
Data Set Information
Data Set and
Diagnostic Criteria Familiesa Triadsa DSPsa Subjects
AGRE Ib:
Narrow 166 262 134 689
Broad 167 322 168 750
AGRE IIc:
Narrow 211 342 225 1,033
Broad 222 434 269 1,071
NIMH:
Narrow 127 228 71 501
Broad 129 237 73 515
a The number of families, triads, and DSPs, as calculated by
PDT (Martin et al. 2000).
b The initial 167 AGRE families (Gharani et al. 2004).
c The additional 222 AGRE families.
(which sums the level of signiﬁcance from all families)
and the PDTave (which gives equal weight to all families
in a data set). Since most families in our study have
similar size and structure and since we observed that the
x2 distribution and P values were similar for both PDT
scores, only PDTsum values are reported in the “Results”
section.
Using a multiplicative model, haplotype relative risk
for the rs1861972-rs1861973 A-C haplotype was esti-
mated as the transmission ratio (transmitted/untrans-
mitted [T/U]) (Altshuler et al. 2000) from heterozygous
parents to a single affected offspring who was selected
randomly from each of the 518 families. TRANSMIT
(version 2.5.4) was used for this analysis because it is
capable of selecting at random a single affected offspring
per family for association analysis. From the output, the
number of informative transmissions (i.e., from hetero-
zygous parents) may be derived (refer to Gharani et al.
[2004] for details), and the transmission ratio can be
estimated. This analysis was repeated 20 times each for
the narrow and broad diagnostic deﬁnitions, and the
mean relative risk was estimated under each diagnosis.
The relative risk and haplotype frequency for the A-C
haplotype were then used to estimate the population-
attributable risk (PAR) by use of the standard formula
, where 2PARp (X 1)/X Xp (1 f )  2f(1 f )g
, f is the haplotype frequency, and g is the haplotype2 2f g
relative risk.
Sequence Analysis
Four overlapping PCR products of the EN2 intron
were PCR ampliﬁed from 20 ASD-affected individuals
who inherited the rs1861972-rs1861973 A-C haplotype
from heterozygous parents. Each PCR product was then
puriﬁed (using QIAGEN-QIAquick PCR Puriﬁcation
Kit) and was sequenced by GENEWIZ on an ABI 3730
DNA analyzer. The sequence was then analyzed for
DNA alterations by use of CodonCode Aligner. The
primer sequences and PCR conditions used for these
experiments are described in appendix B (online only).
En2 Expression Constructs
To misexpress the En2 protein, total RNA was iso-
lated from adult C57BL6/J mouse cerebellum, and a
1,012-bp PCR product that includes the En2 protein-
coding sequence was ampliﬁed by RT-PCR (Superscript
RT) and was then subcloned 3′ of a CMV protein/en-
hancer. PCR was conducted in a 25-ml reaction contain-
ing 0.4 mM of each primer, 0.25 mM dNTP, 1.5 mM
MgCl2, 25 mM KCl, and 10 mM Tris-HCl (pH 8.3).
Cycling conditions were an initial cycle at 94C for 4
min; 35 cycles at 94C for 45 s, 61C for 1 min, and
74C for 2 min; and a ﬁnal step at 74C for 10 min.
The primer sequences were 5′-GTGAAGTATGGAGGA-
GAAGG-3′ for the forward primer and 5′-CTAAACAG-
TCCCCTTTGCAG-3′ for the reverse primer. The PCR
product was isolated by 0.8% agarose gel electropho-
resis, was puriﬁed, and was cloned into the pCR2.1 vec-
tor (Invitrogen). EcoRI restriction-enzyme digest was
used to clone the En2 cDNA into the pCMS-EGFP ex-
pression vector (Clontech).
Cell Culture and cDNA Transfections
Time-mated pregnant Sprague Dawley rats were ob-
tained from Hilltop Labs. At embryonic day 14.5
(E14.5), embryonic skull and meninges were removed,
and dorsolateral cerebral cortex was dissected, was me-
chanically dissociated, and was plated at cells/48# 10
cm2 on poly-D-lysine (0.1 mg/ml) and laminin (20 mg/
ml)–coated 25-mm glass coverslips (VWR) in deﬁned
medium, as described elsewhere (Nicot and DiCicco-
Bloom 2001). Culture medium consisted of Neurobasal
(Gibco) supplemented with 2% B27 and contained glu-
tamine (2 mM), penicillin (50 U/ml), streptomycin (50
mg/ml), BSA (1 mg/ml), and basic ﬁbroblast growth fac-
tor (10 ng/ml). Unless stated otherwise, components
were obtained from Sigma. Cultures were maintained in
a humidiﬁed 5% CO2/air incubator at 37C.
After 24 h in culture, cells were transfected as de-
scribed elsewhere (Nicot and DiCicco-Bloom 2001)
using, for 5 h, Lipofectamine Plus Reagent (BRL) con-
taining one of the following: (1) the mouse En2 en-
hanced green ﬂuorescent protein (EGFP)–expression
plasmid that codes for a full-length En2 protein with
93% nucleotide identity with rat En2; (2) pCMS-EGFP
with En2 cloned in the non–protein-coding reverse ori-
entation (REn2); or (3) pCMS-EGFP alone. After an
additional day of incubation, cells were ﬁxed with 4%
paraformaldehyde and were assessed using phase and
ﬂuorescence microscopy.
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Table 2
Association Results for rs1861972 and rs1861973 in Additional Data Sets
DATA SET, SNP,a
AND DIAGNOSTIC
CRITERIA
PARENTAL
TRANSMISSIONSb
ALLELE IN
DSP SIBLINGSc
x2
VALUEd
P
VALUEeTransmitted Untransmitted Affected Unaffected
AGRE If:
rs1861972:
Narrow 383 354 202 185 4.991 .0255
Broad 467 436 253 226 5.861 .0155
rs1861973:
Narrow 373 338 199 183 6.936 .0084
Broad 449 415 242 220 6.297 .0121
AGRE IIg:
rs1861972:
Narrow 438 408 314 297 2.997 .0834
Broad 555 513 381 359 4.730 .0296
rs1861973:
Narrow 433 395 308 285 4.903 .0268
Broad 546 500 375 346 6.299 .0121
NIMH:
rs1861972:
Narrow 222 200 113 107 4.000 .0455
Broad 228 206 115 109 3.843 .0500
rs1861973:
Narrow 227 203 111 104 5.139 .0234
Broad 234 209 113 105 5.585 .0181
a For rs1861972, theMAFwas 0.269 and 0.317 in the AGRE II andNIMHdata sets, respectively;
for rs1861973, the MAF was 0.279 and 0.295, respectively.
b The number of times the common allele was transmitted and not transmitted from parents to
affected offspring.
c The total number of occurrences of the common allele in affected siblings and unaffected siblings
of DSPs.
d Global x2 values calculated by PDTPHASEsum (Dudbridge 2003).
e P values generated by PDTPHASEsum (1 df). P values in bold italics represent signiﬁcant
( ) associations.P ! .05
f The initial 167 AGRE families (Gharani et al. 2004).
g The additional 222 AGRE families.
En2 RT-PCR Expression Analysis
Total RNA was isolated from freshly dissected E14.5
rat cortices and hindbrains, and the expression of En2
was determined by PCR ampliﬁcation of a 220-bp 3′-
UTR PCR product in a 25-ml reaction containing 0.4
mM of each primer, 0.25 mM dNTP, 1.5 mM MgCl2,
25 mM KCl, and 10 mM Tris-HCl at pH 8.3. Cycling
conditions were an initial cycle at 94C for 4 min; 35
cycles at 94C for 45 s, 56C for 1 min, and 74C for
90 s; and a ﬁnal step at 74C for 10 min. The primer
sequences were 5′-AACCGTGAACAAAAGGCCAGTG-
3′ for the forward primer and 5′-CTAAACAGTCCCCT-
TTGCAG-3′ for the reverse primer.
Immunocytochemistry
Immunocytochemistry was performed as described
elsewhere (Nicot and DiCicco-Bloom 2001). The dilu-
tions of primary and secondary antibodies used were
polyclonal chicken anti-GFP (1:8,000 [Chemicon]),
polyclonal goat anti-En2 (1:500 [Santa Cruz]), anti-
mouse bIII-tubulin (1:1,500 [Covance]), Alexa Fluor
488-conjugated rabbit anti-chicken IgG (1:800 [Chem-
icon]), and Alexa Fluor 594-conjugated rabbit anti-goat
or goat anti-mouse IgG (1:1,000 [Vector]).
Results
Replication Studies
Our previous analysis demonstrated that the A allele
of rs1861972 and the C allele of rs1861973 were sig-
niﬁcantly associated with ASD individually and as a hap-
lotype, under both narrow and broad diagnostic criteria
(Gharani et al. 2004). Replication of these association
results in an additional 222 AGRE families (AGRE II)
and in 129 NIMH families was observed in the present
study.
For the AGRE II data set, signiﬁcant ( ) evi-P ! .05
dence of association for the A allele of rs1861972 was
observed under the broad diagnostic criteria, whereas a
trend toward association was observed under the nar-
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Table 3
Haplotype Association Results for the rs1861972-rs1861973 Haplotype in Additional Data Sets
DATA SET,
DIAGNOSTIC CRITERIA,
AND HAPLOTYPEa
PARENTAL
TRANSMISSIONSb
HAPLOTYPE IN
DSP SIBLINGSc
FREQUENCY
x2
VALUEd
P
VALUEeTransmitted Untransmitted Affected Unaffected
AGRE If:
Narrow:
A-C 369 323 195 179 .732 … .0024
A-T 8 25 5 4 .014 … …
G-C 4 15 4 4 .006 … …
G-T 111 129 52 69 .247 … .0714
Global … … … … … 14 .0009
Broad:
A-C 444 399 238 216 .734 … .0039
A-T 11 28 5 4 .016 … …
G-C 5 16 4 4 .007 … …
G-T 140 157 69 92 .243 … .0765
Global … … … … … 13 .0017
AGRE IIg:
Narrow:
A-C 429 386 308 285 .713 … .0168
A-T 4 16 2 5 .017 … …
G-C 2 8 0 0 .007 … …
G-T 161 186 128 148 .263 … .0928
Global … … … … … 11 .0048
Broad:
A-C 540 487 375 346 .721 … .0061
A-T 6 18 2 6 .014 … …
G-C 2 11 0 0 .006 … …
G-T 210 242 149 174 .259 … .0493
Global … … … … … 13 .0016
NIMH:
Narrow:
A-C 221 198 111 104 .676 … .0321
A-T 1 2 0 1 .007 … …
G-C 6 5 0 0 .025 … …
G-T 78 101 27 34 .292 … .0329
Global … … … … … 6.1 .0463
Broad:
A-C 227 204 113 105 .672 … .0312
A-T 1 2 0 2 .008 … …
G-C 7 5 0 0 .023 … …
G-T 81 105 29 35 .296 … .0295
Global … … … … … 6.3 .0431
a The frequency of the A-C haplotype was 0.715 and 0.680 in the AGRE II and NIMH data sets, respectively.
b The number of times the test haplotype was transmitted and not transmitted from parents to affected offspring.
c The total number of occurrences of the test haplotype in affected siblings and unaffected siblings of DSPs.
d Global x2 values calculated by PDTPHASEsum (Dudbridge 2003), restricted to common haplotypes with frequency15%.
e P values generated by PDTPHASEsum (1 df for single haplotype; 2 df for the global tests). P values in bold italics
represent signiﬁcant ( ) associations for the rs1861972-rs1861973 A-C haplotype.P ! .05
f The initial 167 AGRE families (Gharani et al. 2004).
g The additional 222 AGRE families.
row diagnostic criteria (table 2). For rs1861973, signif-
icant association of the C allele was observed under both
diagnostic criteria (table 2). Analysis of rs1861972-
rs1861973 haplotypes demonstrated that the A-C hap-
lotype was signiﬁcantly overtransmitted to affected off-
spring under both diagnostic criteria (table 3), whereas
the A-T, G-C, and G-T haplotypes were all undertrans-
mitted. Global x2 tests for all haplotypes yielded signif-
icant P values (narrow ; broad )Pp .0048 Pp .0016
(table 3) that were similar to those reported previously
for the AGRE I data set (Gharani et al. 2004). Thus,
replication of our previous results of association of these
same alleles of rs1861972 and rs1861973 with ASD is
observed in this second AGRE data set.
Since identical criteria have been used to obtain all
the AGRE pedigrees, the AGRE I and AGRE II data
858 Am. J. Hum. Genet. 77:851–868, 2005
sets were combined, and association of rs1816972
and rs1861973 with ASD was reanalyzed. Smaller P
values were observed in the combined set than in ei-
ther data set alone (for the haplotype, narrow Pp
and broad ), indicating that the.0000067 Pp .0000033
same alleles are associated with ASD in both data sets.
Association of rs1861972 and rs1861973 was then
tested in the NIMH data set. Statistically signiﬁcant as-
sociation was obtained for the SNPs individually (table
2) and as a haplotype (table 3). As expected, when the
NIMH data set was combined with both AGRE data
sets and reanalyzed for association, further reduction of
the P values was observed (for rs1861972-rs1861973
haplotype, narrow and broadPp .00000065 Pp
). These data represent one of the most sig-.00000035
niﬁcant associations of any gene with ASD. Given the
large sample size (518 families), these results implicate
an inherited variation in EN2 in susceptibility to ASD.
Since a P value is not a measure of effect size, we used
this large combined sample of 518 families to estimate
the relative risk and the associated PAR under a mul-
tiplicative model for the A-C haplotype. The haplotype
relative risk was estimated as ∼1.42 and 1.40 under the
narrow and broad diagnoses, respectively. Although this
represents a relatively modest increase in individual risk,
given the high frequency of this common haplotype
(∼67% in the combined sample), relative risks of 1.42
and 1.40 correspond to a large PAR of ∼39.5% and
38% for the narrow and broad diagnoses of ASD, re-
spectively. These data imply that as many as 40% of
ASD cases in the population may be inﬂuenced by var-
iation in the EN2 gene.
We have previously demonstrated that rs1861972 and
rs1861973 are in strong LD with each other (Gharani
et al. 2004). Similar results were obtained in both new
data sets (AGRE II, ; NIMH, ).′ ′D p 0.967 D p 0.977
In addition, the allele frequencies for rs1861972 and
rs1861973 in both new data sets are almost identical to
each other and to what we reported previously for the
AGRE I data set (Gharani et al. 2004) (ﬁg. 1). This,
together with the association results obtained in the new
samples, suggests that they are likely to be derived from
the same population and are therefore likely to share a
similar LD relationship with the putative etiological
variant.
Extension of LD Map in the AGRE I Data Set
Our previous analysis of the original AGRE I data set
suggested that rs1861972 and rs1861973 are nonfunc-
tional polymorphisms in LD with a risk allele(s) located
elsewhere in the gene (Gharani et al. 2004). In an attempt
to identify this risk allele, the LD map was extended in
the original AGRE I data set. This data set was selected
for LD mapping because it displays the most signiﬁcant
association for rs1861972 and rs1861973, both indi-
vidually and as a haplotype, and therefore represents a
minimal cost-effective sample set with sufﬁcient power
to detect the putative risk allele. Fourteen additional
polymorphisms (3 in the promoter, 10 in the intron, and
1 in the 3′ UTR) were tested for association with ASD,
making a total of 18 markers typed across the entire
gene. Thirteen of these newly typed polymorphismswere
identiﬁed through dbSNP, whereas one (ss38341503)
was identiﬁed by resequencing the entire intron in 20
individuals with ASD who inherited the rs1861972-
rs1861973 A-C haplotype from heterozygous parents.
The location, DNA change, and minor-allele frequency
(MAF) of each polymorphism are illustrated in ﬁgure 1.
In the absence of knowledge about the exact mode of
inheritance at this locus, we may expect the risk allele(s)
responsible for rs1861972 and rs1861973 association
to exhibit the following inheritance pattern. First, the
polymorphism(s) should display strong LD ( )′D 1 0.70
with both rs1861972 and rs1861973 and, therefore,
would be expected to have a similar frequency as the
A-C haplotype. Second, the polymorphism(s) should
also be associated with ASD individually. If a single
polymorphism is responsible for the association of
rs1861972 and rs1861973, then this polymorphism
should demonstrate at least as signiﬁcant an associa-
tion as the A-C haplotype under both the narrow and
broad diagnostic criteria. However, if multiple alleles are
working in concert and we assume a simple additive
model, then each of these polymorphisms should display
association with ASD individually because they will be
in strong LD with rs1861972 and rs1861973, but their
statistical signiﬁcance may not be as great as when they
are analyzed as a haplotype. Third, in multi-SNP hap-
lotype analysis for a single-locus model, the associated
allele in conjunction with the A-C haplotype should dis-
play at least as signiﬁcant an association as the A-C
haplotype alone. In a multilocus model, only the hap-
lotypes with all or most of the risk alleles will display
the greatest statistical signiﬁcance.
When the 14 additional polymorphisms were tested
for association, 12 displayed no evidence of association
under both the narrow and broad diagnoses (table 4).
Two intronic SNPs, rs3824068 and rs2361688, dis-
played minimally signiﬁcant association, but only un-
der one diagnosis (table 4). To investigate whether
rs3824068 and rs2361688 could be functioning in a
multilocus manner, three- and four-marker haplotype
analyses with the rs1861972-rs1861973 A-C haplo-
type were performed. For the rs3824068-rs2361688-
rs1861972-rs1861973 and the rs3824068-rs1861972-
rs1816973 haplotype analyses, all common core A-C
haplotypes (frequency 15%) displayed no association,
except for the rs3824068-rs1861972-rs1816973 T-A-C
haplotype, which displayed minimal association under
Table 4
Association Analysis for 14 Additional Polymorphisms in the AGRE I Data Seta
POLYMORPHISM
AND DIAGNOSTIC
CRITERIA
PARENTAL
TRANSMISSIONSb
ALLELE IN
DSP SIBLINGSc
x2
VALUEd
P
VALUEeTransmitted Untransmitted Affected Unaffected
rs6150410:
Narrow 317 317 183 189 .081 .776
Broad 394 384 234 239 .043 .835
PvuII:
Narrow 253 249 127 131 .000 1.000
Broad 306 303 163 162 .025 .875
rs1345514:
Narrow 271 278 165 168 .220 .639
Broad 332 331 211 215 .015 .902
rs3735652:
Narrow 274 291 156 168 1.532 .216
Broad 350 357 203 220 .867 .352
rs6460013:
Narrow 467 466 249 246 .364 .546
Broad 568 569 314 309 .381 .537
rs7794177:
Narrow 425 414 239 237 1.374 .241
Broad 519 509 295 299 .237 .626
rs3824068:
Narrow 280 316 156 166 4.372 .036
Broad 355 384 205 215 2.664 .103
rs2361688:
Narrow 347 328 193 183 2.317 .128
Broad 423 394 243 224 4.208 .040
rs3824067:
Narrow 370 357 213 214 .581 .446
Broad 443 438 263 267 .003 .959
ss38341503:
Narrow 464 458 266 265 1.581 .209
Broad 565 559 334 332 1.684 .194
rs3808332:
Narrow 361 361 208 208 .000 1.000
Broad 433 440 260 261 .173 .677
rs3808331:
Narrow 421 417 243 245 .040 .841
Broad 519 510 309 310 .525 .469
rs4717034:
Narrow 365 362 205 212 .056 .812
Broad 436 444 257 267 .802 .370
rs3808329:
Narrow 424 405 229 243 .108 .742
Broad 516 491 289 303 .434 .510
a The initial 167 AGRE families (Gharani et al. 2004).
b The number of times the common allele was transmitted and not transmitted from parents to
affected offspring.
c The total number of occurrences of the common allele in affected siblings and unaffected siblings
of DSPs.
d Global x2 values calculated by PDTPHASEsum (Dudbridge 2003).
e P values generated by PDTPHASEsum (1 df). P values in bold italics represent signiﬁcant
( ) associations.P ! .05
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Table 5
Three-Marker Haplotype Analysis of the rs1861972-
rs1861973 Haplotype in the AGRE I Data Set
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 6
Haplotype Analysis of the rs3824068-rs2361688-
rs1861972-rs1861973 Haplotype in the AGRE I Data Set
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
one diagnosis (tables 5 and 6). For the rs2361688-
rs1861972-rs1861973 analysis, the G-A-C haplotype
displayed similar statistical signiﬁcance as the A-C hap-
lotype under the broad diagnosis, but, under the narrow
diagnosis, the effect was diluted (table 5). Four other
common three-marker A-C haplotypes (rs6460013-
rs1861972-rs1861973 G-A-C, rs7794177-rs1861972-
rs1861973 C-A-C, rs1861972-rs1861973-ss38341503
A-C-C, and rs1861972-rs1861973-rs3808329 A-C-A)
displayed similar statistically signiﬁcant association as
the A-C haplotype under at least one diagnostic deﬁ-
nition (table 5). However, rs6460013, rs7794177,
ss38341503, and rs3808329 were not associated indi-
vidually with ASD, which indicates that these polymor-
phisms are not functioning as risk alleles according to
our criteria.
The intermarker LD relationships for these 14 poly-
morphisms plus the 4 previously tested SNPs were then
examined. All promoter, exonic, and 3′-UTR polymor-
phisms displayed weak or intermediate LD (D′ range
0.024–0.632) with both rs1861972 and rs1861973, pro-
viding an explanation as to why they are not associated
with ASD (ﬁg. 2A). However, all new intronic SNPs
displayed strong LD (D′ range 0.720–1.00) with both
rs1861972 and rs1861973 (ﬁg. 2A). The lack of asso-
ciation with ASD observed for eight of the intronic
SNPs suggests that these intronic variants are in weaker
LD with the risk allele than are SNPs rs1861872 or
rs1861973. This reduced power to detect LD may be
the result of differences in allele frequencies and may
reﬂect the genetic history of when these intronic alleles
arose in relation to the risk allele. Evidence for some
association of rs2361688 and rs3824068 with ASD
suggests that these variants are in stronger LD with the
risk allele(s) than the other newly genotyped intronic
SNPs.
One plausible interpretation of the strong LD ob-
served between the intronic SNPs and rs1861972 and
rs1861973, as well as the decay of LD for ﬂanking
polymorphisms, is that the risk allele is situated at
∼3.0 kb in the intron. Sequence analysis of the intron
in 20 individuals affected with ASD who inherited the
rs1861972-rs1861973 A-C haplotype from hetero-
zygous parents has identiﬁed only one novel SNP
(ss383341503) with an MAF of 1%, indicating that
additional common intronic polymorphisms are un-
likely. We have now tested all intronic SNPs, and only
rs1861972 and rs1861973 are consistently associated
both individually and as a haplotype under both diag-
nostic criteria. Together, these analyses suggest that the
A allele of rs1861972 and the C allele of rs1861973may
function as risk alleles in cis and suggest that the lack
of association of some of the core A-C haplotypes iden-
tiﬁed in the multi-SNP haplotype analysis is because of
other, unidentiﬁed epistatic genetic or environmental
interactions. Comparative genomic studies of human,
chimp, mouse, rat, and dog sequences do not place either
SNP within conserved regions (data not shown). How-
ever, computer prediction programs have determined
that the associated alleles of rs1861972 and rs1861973
are situated within consensus binding sites for the CBP
and LvC transcription factors, respectively (see TRANS-
FACWeb site). For the associated alleles, the match ratio
for each transcription factor was 100%. The nonasso-
ciated alleles alter a conserved nucleotide in the consen-
sus binding site, and so, when the sequence was re-
analyzed, the nonassociated alleles were predicted to
abolish the binding of both transcription factors.
Effects of En2 Misexpression on Neurogenesis
Risk alleles of human EN2 associated with ASD may
potentially alter the spatial and/or temporal expression
of the gene during brain development. To begin exam-
ining the consequences of gene misexpression, we trans-
fected the En2 EGFP vectors into cultures of primary
neuronal precursors obtained from rat E14.5 cerebral
cortex. The expression plasmid alone (pCMS-EGFP) or
with En2 cloned in the reverse orientation (REn2) was
used as a control. We have previously used this well-
characterized model system to deﬁne the effects of ex-
tracellular signals and transfected genes on cortical neu-
rogenesis (Lu and DiCicco-Bloom 1997; Nicot and
DiCicco-Bloom 2001; Carey et al. 2002). En2 is not
expressed in E14.5 rat cortical cells, as assessed by RT-
PCR (ﬁg. 3A), so our experiments deﬁne the effects of
En2 misexpression in a naive cell population. At 24 h
after transfection, all three vectors generated similar
numbers of EGFP-expressing cells (pCMS-EGFP, 174.5
 45.1; REn2, 201 20.4; En2, 163.3 11.9 [GFP
cells  SEM]; ), as detected by EGFP autoﬂuo-P 1 .05
rescence and immunocytochemistry, which suggests that
vector expression per se is not deleterious. As expected,
En2 protein immunoreactivity was detected only in
EGFP-positive, En2-transfected cells, but not in REn2-
or EGFP-transfected cells (data not shown).
We initially examined the effects of vector expression
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Figure 2 Intermarker LD values. A, Tabular representation of the pairwise LD (D′) values between the 18 polymorphisms tested for
association in the AGRE I data set. The LD relationships of each polymorphism with rs1861972 and rs1861973 are highlighted, with the degree
of shading corresponding to the strength of LD: black indicates strong LD (D′ 1 0.72); gray indicates intermediate/weak LD (D′ range 0.024–
0.632). B, The EN2 gene is illustrated with the position of all 18 tested polymorphisms demarcated by arrows. The decay of LD of each
polymorphism with respect to rs1861972 and rs1861973 is represented by a gradient bar drawn below the gene. The degree of shading
corresponds to the strength of LD, as described above. Only intronic polymorphisms are in strong LD with rs1861972 and rs1861973.
on cortical cell morphology, assessing undifferentiated
precursors and mature neurons (ﬁg. 3B–3D). Undiffer-
entiated neural precursors appear as ﬂat cells that some-
times extend processes of variable diameter and length,
with distal ﬁlopodia. Precursors do not express the early
marker of neuronal differentiation: cytoskeletal protein
bIII-tubulin (ﬁg. 3D). Differentiated neurons exhibit a
round or pyramidal cell body, extend thin uniform pro-
cesses, and express bIII-tubulin (ﬁg. 3B–3D). In cultures
transfected with control vectors, approximately equal
proportions of cells exhibited morphologies of precur-
sors and neurons (ﬁg. 3E and 3F), reproducing ratios
obtained previously with this model (Nicot andDiCicco-
Bloom 2001). In contrast, after En2 transfection, the
proportion of undifferentiated precursors increased from
55% in controls to 71% in En2-transfected cells (ﬁg.
3E). Since overall numbers of cells were similar across
conditions, the increase in precursors occurred at the
expense of cells exhibiting neuronal morphology—neu-
rons decreased from 45% in controls to only 29% after
En2 transfection (ﬁg. 3F). The reduction in neuronal
differentiation was further veriﬁed by assessment of bIII-
tubulin expression, which was decreased by 55% in
En2-transfected cells (ﬁg. 3G), raising the possibility that
altered cytoskeletal protein expression may underlie
changes observed in cellular morphology elicited byEn2.
These data demonstrate that En2 ectopic expression dis-
rupts neuronal differentiation, indicating that the gene
is an important regulator of neuronal development.
Discussion
In this study, we provide further genetic support that
EN2 is involved in ASD susceptibility. Evidence for as-
sociation is presented for rs1861972 and rs1861973 in
the AGRE II and NIMH data sets. PAR estimations cal-
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Figure 3 Effects of En2 misexpression on neurogenesis. A, No
En2 expression in rat cerebral cortex. En2 expression was detected
by RT-PCR of RNAs obtained from freshly dissected E14.5 rat cortex
(Ctx) and hindbrain (HB). The primers ampliﬁed the same 220-bp
region of the En2 3′ UTR from both genomic mouse (Ms) and rat
DNAs, consistent with the high degree of nucleotide homology. No
expression was found in rat cortex, whereas a high level was detected
in the hindbrain, recapitulating the known expression pattern of En2.
/ RT p with/without reverse transcriptase; Con p control. B–D,
Transfected cortical cells exhibiting morphologies of undifferentiated
precursors and differentiated neurons. The arrowheads denote cells
with precursor morphology, whereas the arrows identify cells with
neuronal morphology. Magniﬁcation 40#; scale bar p 30 mm. B,
Phase photomicrograph demonstrating cells with both precursor and
neuronal morphologies. Note the large, ﬂat cell bodies and the thick,
tapering, and short processes of the precursors (arrowhead). In con-
trast, neuron-like cells exhibit round cell bodies with long, thin, and
uniform-diameter processes (arrow). C, Examples of both precursors
and neurons transfected with the En2 vectors and identiﬁed for gene
expression by immunostaining for EGFP marker protein. D, Cultures
that were double labeled to detect EGFP and neuron-speciﬁc cyto-
skeletal protein bIII-tubulin (TuJ1), an early marker of neuronal dif-
ferentiation. TuJ1 expression was only detected in cells exhibiting neu-
ronal morphologies, a ﬁnding consistent with our previous studies
(Nicot and DiCicco-Bloom 2001). E, Increase in the proportion of
GFP precursor cells, noted 24 h after En2 transfection. F, Corre-
sponding decrease in the proportion of En2-transfected cells exhibiting
neuronal morphology. G, En2 transfection elicited a 150% reduction
in TuJ1-immunoreactive cells, a change that parallels the decrease in
neuronal morphology. ** , ; *** ,8P ! .0005 Np 9 P ! 4# 10 Np
.15
culated using the entire sample of 518 families indicate
that the risk allele responsible for rs1861972-rs1861973
association contributes to ∼40% of ASD cases in the
general population. In addition, LD mapping with 18
SNPs distributed across the gene has currently localized
the associated genomic region to the intron (ﬁg. 2B).
Analysis of this region has identiﬁed associated intronic
alleles that will be characterized, in the future, for func-
tional differences. Future LD studies will also examine
the possibility of more-complex LD patterns across the
gene, extending to 5′ and 3′ genomic regions. Finally, we
also demonstrate that ectopic misexpression of En2 dis-
rupts neuronal development. Together, these data sug-
gest that variation within the EN2 gene plays an im-
portant role in ASD etiology and that one or more risk
alleles that cause altered expression of EN2 could per-
turb neuronal development and contribute to the pa-
thology associated with ASD.
A primary objective of this study was to examine
whether our previous association of rs1861972 and
rs1861973 with ASD could be replicated in other data
sets. Many factors may contribute to a lack of repli-
cation in association studies of complex genetic traits
(Terwilliger 2000; Riley 2004; Bartlett et al. 2005). Con-
sequently, the signiﬁcant replication of rs1861972 and
rs1861973 association in the AGRE II and NIMH data
sets strongly supports EN2 as a contributing factor in
ASD etiology. When the transmissions from all three
data sets were combined and analyzed, highly signiﬁcant
evidence of association was obtained. Although a P
value is not a measure of effect size, these data dem-
onstrate that EN2 association with ASD is maintained
in this larger sample. The combined data set includes
518 families, or 2,336 individuals, and is one of the
largest samples in which an association study for ASD
has been conducted. The fact that very signiﬁcant as-
sociation is observed in this large sample recruited from
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multiple sources supports the possibility that EN2 is a
risk factor for ASD and that EN2 contributes to ASD
susceptibility in the general population.
Given that our replication data provided genetic evi-
dence for a risk allele situated within EN2, LDmapping
was used to localize the genomic position of the risk
allele(s). The rs1861972-rs1861973 A-C haplotype has
consistently demonstrated similar or more-signiﬁcant
association than either SNP individually. In addition,
three- and four-SNP haplotypes that contain a core A-
C haplotype are not consistently overtransmitted (Ghar-
ani et al. 2004) (table 5). These data have been inter-
preted as an indication that rs1861972 and rs1861973
are not risk alleles but, instead, are nonfunctional poly-
morphisms in LD with an unidentiﬁed risk allele. Eigh-
teen polymorphisms, including the new intronic SNP
(ss38341503) identiﬁed in our samples, have now been
tested for association. According to dbSNP (build 124),
35 EN2 polymorphisms have been identiﬁed in theEN2
gene and 2.5 kb of promoter sequence. dbSNP reports
13 polymorphisms in the promoter, 2 in the protein-
coding sequence, 11 in the intron, and 9 in the 3′ UTR.
We have tested 3 of the 13 promoter polymorphisms,
11 of the 11 intronic SNPs, both protein-coding SNPs,
and 1 polymorphism in the 3′ UTR. Thus, a signiﬁcant
proportion of the polymorphisms annotated for EN2
have now been tested for association.
Of the 14 newly genotyped SNPs, only 2 intronic
SNPs (rs2361688 and rs3824068) individually exhibit
minimal association with ASD. However, given that, for
both these SNPs, association is only detected under a
single diagnostic deﬁnition and that the signiﬁcance
level of this association is less than that obtained for
the rs1861972-rs1861973 A-C haplotype, these vari-
ants are not thought to function as risk alleles under a
single-locus model. Detection of LD between a disease
locus and a marker is dependent on various factors,
including disease and marker allele frequencies, recom-
bination rates, and the population history. In particular,
it has been shown that the greatest power to detect LD
is obtained if the frequency of the marker allele is at
least as large as the frequency of the causative mutation
(Garner and Slatkin 2003). Given that the greatest as-
sociation with ASD has been obtained for the common
A-C haplotype of rs1861872-rs1861973 (with a fre-
quency of 167%), this suggests that the risk allele is
also likely to have a high frequency. The MAF of all
intronic SNPs ranges from 1% to 40% (ﬁg. 1), and, in
all cases except rs2361688 (MAF of 27%), it is the
minor allele that is in LD with the common alleles of
rs1861872 or rs1861973 (data not shown). This may
partly explain the observed association for rs2361688
and the lack of detectable associationwith ASD formost
of the other intronic SNPs. Alternatively, the association
of rs2361688 individually and in three-marker haplo-
type analysis may indicate that the associated allele of
rs2361688 could be functioning in a multilocus manner.
Minimal association is also detected for rs3824068 in-
dividually and in a three-SNP haplotype analysis under
the narrow diagnosis only. Examination of the trans-
mission data revealed that the rare T allele of rs3824068
displayed strong LD with the A-C haplotype, whereas
the common C allele of rs3824068 is equally distributed
between the A-C and G-T haplotypes of rs1861872-
rs1861973 (data not shown). Thus, the T allele is almost
always transmitted with a subset of the A-C haplotypes,
and this may explain the weak association with ASD
detected with this marker. These data suggest that
rs3824068 is unlikely to be functional and is most likely
a polymorphism in which the rare T allele is in stronger
LD with the risk allele than are the other, nonassociated
intronic SNPs.
Finally, haplotype analysis has also shown that the
common rs1861872-rs1861973 A-C–containing haplo-
types for markers rs6460013, rs7794177, ss38341503,
and rs3808329 displayed statistically signiﬁcant asso-
ciation, similar to that of the A-C haplotype alone, un-
der at least one diagnostic deﬁnition. However, these
SNPs were not associated individually with ASD and
therefore are not likely to function as risk alleles in a
single-locus model. Furthermore, none of the three-SNP
haplotype analyses resulted in a dramatic reduction of
the P value, which indicates that these polymorphisms
are likely not functioning in a multilocus manner and
that the minor ﬂuctuations in P values reﬂect the strong
LD that exists between these haplotypes and the risk
allele.
In summary, our analysis thus far has demonstrated
that only rs1861972 and rs1861973 are consistently
and signiﬁcantly associated with ASD alone and as a
haplotype under both narrow and broad diagnostic cri-
teria. We propose two alternate hypotheses to explain
our current LD and association data. The ﬁrst hypoth-
esis is that the ASD risk allele(s) responsible for the
rs1861972 and rs1861973 association is located in the
intron of EN2. Resequencing of the intron identiﬁed
only one additional rare SNP, which indicated that fur-
ther common SNPs of similar frequency as that of the
rs1861972-rs1861973 A-C haplotype are unlikely.
Moreover, single- and multi-SNP association data in-
dicate that rs1861972 and rs1861973, and possibly
rs2361688, are candidate risk alleles that function to-
gether in cis to increase risk for ASD. The lack of as-
sociation for some core A-C haplotypes in our three-
and four-marker haplotype analysis could then be the
result of unidentiﬁed epistatic genetic or environmental
factors (Gharani et al. 2004). The prediction that the
nonassociated G-T haplotype could potentially disrupt
the binding of the LvC and CBP transcription factors
supports this hypothesis. The Ets family of transcription
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factors has been shown to bind to the LvC consensus
sequence, which has been implicated in neuronal dif-
ferentiation (Gunther and Graves 1994; Hippenmeyer
et al. 2005). CBP acts as a coactivator that promotes
the interaction between tissue-speciﬁc transcription fac-
tors and the basal transcriptional machinery (Song et
al. 2002). The nonassociated alleles of rs186172 and
rs1861973 may then inﬂuence the expression of EN2,
but it has yet to be demonstrated that the intron acts
as a cis-regulatory sequence. Ongoing expression anal-
ysis is being done to investigate whether the intron acts
as a cis-regulatory element and, if so, whether these
putative transcription factor binding sites contribute to
its activity.
The second, equally possible hypothesis is that the
risk allele(s) maps outside the tested region or to some
segment of the promoter or 3′ UTR that is in LD with
rs1861972 and rs1861973. Future LD and association
analyses of all markers mapped within the entire EN2
locus will investigate the possibility of more-complex
LD patterns across the gene, such as the LD interdigi-
tations across haplotype blocks that have been observed
for a number of genomic regions (Carlson et al. 2004;
Hinds et al. 2005).
Although the identity of the risk allele(s) is yet to be
deﬁned, we used this large combined sample of 518
families in an attempt to quantify the effect of this locus
on ASD susceptibility. We estimated a modest relative
risk for the predisposing A-C haplotype, but, because
the risk haplotype occurs at such a high frequency, this
translates into a large PAR—an inﬂuence on as many
as 40% of autism cases in the general population. These
data suggest a highly signiﬁcant role for variation at
this locus in the etiology of ASD.
Since the relative risk and PAR are calculated from
sample populations ascertained for multiple affected
siblings, the actual risk estimates may be different in
the general ASD population. Estimates of relative risk
in multiplex sibships, compared with singleton families,
are thought to be distorted depending on the back-
ground heritability (a multilocus model of the disorder).
In the case of multiplex families, the relative risk is, in
fact, expected to be deﬂated at a rate that is proportional
to the increase in background heritability and to be
more accurately estimated in situations of low back-
ground heritability (Risch 2001). Given the complex
polygenic model of inheritance, with anywhere between
3 and 15 interacting loci, that has been proposed for
ASD (Risch et al. 1999), it is not clear how the true
mode of inheritance in our sample may have affected
our risk estimates. Further studies in other populations
or single-ascertainment family-based data sets should
conﬁrm the true impact of this locus.
EN2maps to chromosome 7q36, and suggestive link-
age has been observed for this region in two different
studies that used the AGRE data set (Liu et al. 2001;
Alarcon et al. 2002). In the initial linkage analysis using
110 AGRE families, ﬁnemapping on distal chromosome
7 demonstrated that D7S483, located 5.5 Mb proximal
to EN2, displayed a LOD score of 2.13 (Liu et al. 2001).
QTL analysis using the same set of microsatellite mark-
ers and 152 AGRE families demonstrated suggestive
linkage of QTLs implicated in general language perfor-
mance to 7q36 ( ) (Alarcon et al. 2002). Re-Pp .001
cently, Yonan et al. (2003) performed a genome scan
on a set of 345 AGRE families (which includes most of
the AGRE I and AGRE II samples in our present study)
and observed only minimal linkage at distal chromo-
some 7 ( ). However, since none of these stud-LOD ! 1.3
ies used markers that are distal to EN2, it is difﬁcult to
determine whether the contribution of EN2 to these
linkage ﬁndings has been properly assessed. Genome-
scan analysis of the NIMH data set also provided a
nominal positive LOD score for chromosome 7q; how-
ever, this was at marker D7S1804 (maximum LOD
score 0.93), which is ∼23 Mb proximal to EN2 (Risch
et al. 1999). Given the modest relative risk and high
haplotype frequency of the A-C predisposing haplotype,
it is likely that the risk allele(s) at this locus will typically
be transmitted from both parents, making the contri-
bution of this locus difﬁcult to detect by conventional
linkage analysis (Risch and Merikangas 1996). Despite
the high population impact of this common risk variant,
very large samples may be required to obtain a signif-
icant LOD score. Considering our association results
and the availability of this large sample set of 1500
families, it will now be worthwhile to further investigate
linkage of 7q36 to ASD by use of a set of genetic mark-
ers that span the EN2 locus.
Previously, a case-control study in a French popula-
tion reported signiﬁcant association of a PvuII RFLP
located in the 5′ region of EN2 with autism (Petit et al.
1995). We have now mapped the position of this poly-
morphism to the promoter region between rs6150410
and rs1345514 and have demonstrated that, within the
original AGRE I data set, this polymorphism is not as-
sociated with ASD. This difference in results could ei-
ther indicate a false-positive result in the case-control
study as a result of population stratiﬁcation or reﬂect
population-speciﬁc variation in LD between markers
and different causal variants within this gene. This last
possibility is consistent with the PvuII RFLP being in
linkage equilibrium with both rs1861972 and rs1861973
in the AGRE I sample.
Our association data, which provide strong genetic
evidence that EN2 is involved in ASD susceptibility, are
further supported by previous mouse functional data
(Millen et al. 1994, 1995; Kuemerle et al. 1997; Baader
et al. 1998, 1999). Two mouse mutants already exist
for En2: a knockout and a transgenic that misexpresses
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the gene in a subset of Purkinje cells. Interestingly, both
mouse mutants cause an autistic-like cerebellar phe-
notype, including hypoplasia and a decrease in the num-
ber of Purkinje cells. Thus, both the activity and the
spatial/temporal regulation of En2 are critical for nor-
mal cerebellar development. Neither mouse mutant
has undergone an extensive behavioral analysis, but
ongoing experiments are investigating whether the En2
knockout mouse displays characteristic behavioral
phenotypes.
Our current studies now provide mechanistic insight
into how risk alleles that affect EN2 expression might
perturb neuronal development. Misexpression of mouse
En2 in primary cortical cultures elicited a reduction in
neuronal differentiation, as reﬂected by the number of
process-bearing neurons that express bIII-tubulin. This
ﬁnding is consistent, at the molecular level, with studies
in which the Drosophila Engrailed protein was shown
to directly repress the expression of bIII-tubulin (Ser-
rano et al. 1997). These results suggest that an ASD
risk allele that alters EN2 mRNA or protein levels or
its spatial/temporal regulation could signiﬁcantly affect
neuronal differentiation.
In conclusion, the data presented in this article pro-
vide further genetic and functional evidence that EN2
may be acting as an ASD susceptibility locus. In light
of the previous studies demonstrating En2 function dur-
ing mouse cerebellar development, the similarities be-
tween mouse En2 mutants and autistic cerebellar phe-
notypes, and the activation of the cerebellum during
cognitive tasks that are abnormal in ASD (Kim et al.
1994; Millen et al. 1994, 1995; Raichle et al. 1994;
Gao et al. 1996; Akshoomoff et al. 1997; Allen et al.
1997; Courchesne and Allen 1997; Kuemerle et al.
1997; Baader et al. 1998, 1999; Allen and Courchesne
2003; Corina et al. 2003; McDermott et al. 2003), our
studies further support the hypothesis that develop-
mental abnormalities of the cerebellum contribute to
the behavioral deﬁcits observed in ASD.
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Web Resources
The URLs for data presented herein are as follows:
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//zork.wustl.edu/nimh/NIMH_initiative/NIMH_initiative_
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Tetra-primer ARMS-PCR, http://cedar.genetics.soton.ac.uk/
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References
Abecasis GR, Cookson WO (2000) GOLD—graphical over-
view of linkage disequilibrium. Bioinformatics 16:182–183
Ahmadian A, Gharizadeh B, Gustafsson AC, Sterky F, Nyren
P, Uhlen M, Lundeberg J (2000) Single nucleotide poly-
morphism analysis by pyrosequencing. Anal Biochem 280:
103–110
Akshoomoff NA, Courchesne E, Townsend J (1997) Attention
coordination and anticipatory control. Int Rev Neurobiol
41:575–598
AlarconM, Cantor RM, Liu J, Gilliam TC, the AutismGenetic
Research Exchange Consortium, GeschwindDH (2002) Evi-
dence for a language quantitative trait locus on chromosome
7q in multiplex autism families. Am J Hum Genet 70:60–
71
Allen G, Buxton RB, Wong EC, Courchesne E (1997) Atten-
tional activation of the cerebellum independent of motor
involvement. Science 275:1940–1943
Allen G, Courchesne E (2003) Differential effects of devel-
opmental cerebellar abnormality on cognitive and motor
functions in the cerebellum: an fMRI study of autism. Am
J Psychiatry 160:262–273
Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM,
Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer
C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L,
Lander ES (2000) The common PPARg Pro12Ala polymor-
phism is associated with decreased risk of type 2 diabetes.
Nat Genet 26:76–80
Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Yli-
saukko-Oja T, Sinsheimer JS, Peltonen L, Jarvela I (2002)
A genomewide screen for autism-spectrum disorders: evi-
dence for a major susceptibility locus on chromosome 3q25-
27. Am J Hum Genet 71:777–790
Baader SL, Sanlioglu S, Berrebi AS, Parker-Thornburg J,
Oberdick J (1998) Ectopic overexpression of Engrailed-2 in
cerebellar Purkinje cells causes restricted cell loss and re-
tarded external germinal layer development at lobule junc-
tions. J Neurosci 18:1763–1773
Baader SL, Vogel MW, Sanlioglu S, Zhang X, Oberdick J
(1999) Selective disruption of “late onset” sagittal banding
patterns by ectopic expression of Engrailed-2 in cerebellar
Purkinje cells. J Neurosci 19:5370–5379
Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery
M, Rutter M, Lantos P (1998) A clinicopathological study
of autism. Brain 121:889–905
Bartlett CW, Gharani N, Millonig JH, Brzustowicz LM (2005)
Three autism candidate genes: a synthesis of human genetic
analysis with other disciplines. Int J Dev Neurosci 23:221–
234
Bauman ML, Kemper TL (1985) Histoanatomic observations
of the brain in early infantile autism. Neurology 35:866–
874
——— (1986) Developmental cerebellar abnormalities: a con-
sistent ﬁnding in early infantile autism. Neurology Suppl 1
36:190
——— (1994) Neuroanatomic observations of the brain in
autism. In: The neurobiology of autism. Johns Hopkins Uni-
versity Press, Baltimore, pp 119–145
Carey RG, Li B, DiCicco-Bloom E (2002) Pituitary adenylate
cyclase activating polypeptide anti-mitogenic signaling in ce-
rebral cortical progenitors is regulated by p57Kip2-depen-
dent CDK2 activity. J Neurosci 22:1583–1591
Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nick-
erson DA (2004) Selecting a maximally informative set of
single-nucleotide polymorphisms for association analyses
using linkage disequilibrium. Am J Hum Genet 74:106–120
Corina DP, San Jose-Robertson L, Guillemin A, High J, Braun
AR (2003) Language lateralization in a bimanual language.
J Cogn Neurosci 15:718–730
Courchesne E (1997) Brainstem, cerebellar and limbic neuro-
anatomical abnormalities in autism. Curr Opin Neurobiol
7:269–278
Courchesne E, Allen G (1997) Prediction and preparation, fun-
damental functions of the cerebellum. Learn Mem 4:1–35
Courchesne E, Carper R, Akshoomoff N (2003) Evidence of
brain overgrowth in the ﬁrst year of life in autism. JAMA
290:337–344
Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA,
Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln
AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA,
Courchesne RY (2001) Unusual brain growth patterns in
early life in patients with autistic disorder: an MRI study.
Neurology 57:245–254
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR,
Jernigan TL (1988) Hypoplasia of cerebellar vermal lobules
VI and VII in autism. N Engl J Med 318:1349–1354
Dudbridge F (2003) Pedigree disequilibrium tests for multi-
locus haplotypes. Genet Epidemiol 25:115–121
Folstein S, Rutter M (1977) Infantile autism: a genetic study
of 21 twin pairs. J Child Psychol Psychiatry 18:297–321
Folstein SE, Rosen-Sheidley B (2001) Genetics of autism: com-
plex aetiology for a heterogeneous disorder. Nat Rev Genet
2:943–955
Gaffney GR, Kuperman S, Tsai LY, Minchin S, Hassanein KM
(1987) Midsagittal magnetic resonance imaging of autism.
Br J Psychiatry 151:831–833
Benayed et al.: EN2 Association with ASD 867
Gao JH, Parsons LM, Bower JM, Xiong J, Li J, Fox PT (1996)
Cerebellum implicated in sensory acquisition and discrimi-
nation rather than motor control. Science 272:545–547
Garner C, Slatkin M (2003) On selecting markers for asso-
ciation studies: patterns of linkage disequilibrium between
two and three diallelic loci. Genet Epidemiol 24:57–67
Geschwind DH, Sowinski J, Lord C, Iversen P, Shestack J,
Jones P, Ducat L, Spence SJ, the AGRE Steering Committee
(2001) The Autism Genetic Resource Exchange: a resource
for the study of autism and related neuropsychiatric con-
ditions. Am J Hum Genet 69:463–466
Gharani N, Benayed R,Mancuso V, Brzustowicz LM,Millonig
JH (2004) Association of the homeobox transcription factor,
ENGRAILED 2, 3, with autism spectrum disorder. Mol
Psychiatry 9:474–484
Gunther CV, Graves BJ (1994) Identiﬁcation of ETS domain
proteins in murine T lymphocytes that interact with the
Moloney murine leukemia virus enhancer. Mol Cell Biol 14:
7569–7580
Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Mi-
yazali M, Harada M, Kuroda Y (1995) Development of the
brainstem and cerebellum in autistic patients. J Autism Dev
Disord 25:1–18
Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger
DG, Frazer KA, Cox DR (2005) Whole-genome patterns of
common DNA variation in three human populations. Sci-
ence 307:1072–1079
Hippenmeyer S, Vrieseling E, Sigrist M, Portmann T, Laengle
C, Ladle DR, Arber S (2005) A developmental switch in the
response of DRG neurons to ETS transcription factor sig-
naling. PLoS Biol 3:e159
Iannone MA, Taylor JD, Chen J, Li MS, Rivers P, Slentz-Kesler
KA, Weiner MP (2000) Multiplexed single nucleotide poly-
morphism genotyping by oligonucleotide ligation and ﬂow
cytometry. Cytometry 39:131–140
Kemper TL, Bauman ML (1993) The contribution of neuro-
pathologic studies to the understanding of autism. Behav
Neurol 11:175–187
Kim SG, Ugurbil K, Strick PL (1994) Activation of a cerebellar
output nucleus during cognitive processing. Science 265:
949–951
KleimanMD, Neff S, Rosman NP (1992) The brain in infantile
autism: are posterior fossa structures abnormal? Neurology
42:753–760
Kuemerle B, Zanjani H, Joyner A, Herrup K (1997) Pattern
deformities and cell loss in Engrailed-2 mutant mice suggest
two separate patterning events during cerebellar develop-
ment. J Neurosci 17:7881–7889
Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P,
Geschwind D, Lord C, Iversen P, Hoh J, the Autism Genetic
Resource Exchange Consortium, Ott J, Gilliam TC (2001)
A genomewide screen for autism susceptibility loci. Am J
Hum Genet 69:327–340
Logan C, Joyner AL (1989) PvuII and RsaI RFLPs for the
human homeo box-containing gene EN2. Nucleic Acids Res
17:2879
Lu N, DiCicco-Bloom E (1997) Pituitary adenylate cyclase-
activating polypeptide is an autocrine inhibitor of mitosis
in cultured cortical precursor cells. Proc Natl Acad Sci USA
94:3357–3362
Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test
for linkage and association in general pedigrees: the pedigree
disequilibrium test. Am J Hum Genet 67:146–154
McDermott KB, Petersen SE, Watson JM, Ojemann JG (2003)
A procedure for identifying regions preferentially activated
by attention to semantic and phonological relations using
functional magnetic resonance imaging. Neuropsychologia
41:293–303
Millen KJ, Hui CC, Joyner AL (1995) A role for En-2 and
other murine homologues of Drosophila segment polarity
genes in regulating positional information in the developing
cerebellum. Development 121:3935–3945
Millen KJ, Wurst W, Herrup K, Joyner AL (1994) Abnormal
embryonic cerebellar development and patterning of post-
natal foliation in two mouse Engrailed-2 mutants. Devel-
opment 120:695–706
Murakami JW, Courchesne E, Press GA, Yeung-Courchesne
R, Hesselink JR (1989) Reduced cerebellar hemisphere size
and its relationship to vermal hypoplasia in autism. Arch
Neurol 46:689–694
Nicot A, DiCicco-Bloom E (2001) Regulation of neuroblast
mitosis is determined by PACAP receptor isoform expres-
sion. Proc Natl Acad Sci USA 98:4758–4763
O’Connell JR, Weeks DE (1998) PedCheck: a program for
identiﬁcation of genotype incompatibilities in linkage anal-
ysis. Am J Hum Genet 63:259–266
Palmen SJ, van Engeland H, Hof PR, Schmitz C (2004) Neu-
ropathological ﬁndings in autism. Brain 127:2572–2583
Petit E, Herault J, Martineau J, Perrot A, Barthelemy C,
Hameury L, Sauvage D, Lelord G, Muh JP (1995) Associ-
ation study with two markers of a human homeogene in
infantile autism. J Med Genet 32:269–274
Raichle ME, Fiez JA, Videen TO, MacLeod AM, Pardo JV,
Fox PT, Petersen SE (1994) Practice-related changes in hu-
man brain functional anatomy during nonmotor learning.
Cereb Cortex 4:8–26
Riley B (2004) Linkage studies of schizophrenia. NeurotoxRes
6:17–34
Risch N (2001) Implications of multilocus inheritance for gene-
disease association studies. Theor Popul Biol 60:215–220
Risch N, Merikangas K (1996) The future of genetic studies
of complex human diseases. Science 273:1516–1517
Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer
J, Kalaydjieva L, et al (1999) A genomic screen of autism:
evidence for a multilocus etiology. Am J Hum Genet 65:
493–507
Ritvo ER, Freeman BJ, Mason-Brothers AM,Mo A, Ritvo AM
(1985) Concordance for the syndrome of autism in 40 pairs
of affected twins. Am J Psychiatry 142:74–77
Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H,
Guthrie D, Ritvo A (1986) Lower Purkinje cell count in the
cerebella of four autistic subjects: initial ﬁndings of the
UCLA-NSAC Autopsy Research report. Am J Psychiatry
143:862–866
Ronaghi M, Uhlen M, Nyren P (1998) A sequencing method
based on real-time pyrophosphate. Science 281:363–365
Serrano N, Brock HW, Maschat F (1997) b3-tubulin is directly
repressed by the Engrailed protein in Drosophila. Devel-
opment 124:2527–2536
Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos
868 Am. J. Hum. Genet. 77:851–868, 2005
G (2002) Functional interaction between coactivators CBP/
p300, PCAF, and transcription factor FKLF2. J Biol Chem
277:7029–7036
Terwilliger JD (2000) In: Rao DC, Province MA (eds) Genetic
dissection of complex traits. Vol. 42. Academic Press, New
York, pp 351–391
Weeks DE, Lathrop M (1995) Polygenic disease: methods for
mapping complex disease traits. Trends Genet 11:513–519
Ye S, Dhillon S, Ke X, Collins AR, Day IN (2001) An efﬁcient
procedure for genotyping single nucleotide polymorphisms.
Nucleic Acids Res 29:E88
Yonan AL, Alarcon M, Cheng R, Magnossun PKE, Spence SJ,
Palmer AA, Grunn A, Juo SH, Terwilliger JD, Liu J, Cantor
RM, Geschwind DH, Gilliam TC (2003) A genomewide
screen of 345 families for autism-susceptibility loci. Am J
Hum Genet 73:886–897
